EyePoint Pharmaceuticals, Inc. (29)

Browse by Contract Category

Contracts

EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan, as amended (Filed With SEC on June 24, 2021)
EyePoint Pharmaceuticals, Inc. 2016 Long-Term Incentive Plan, as amended (Filed With SEC on June 24, 2021)
Third Amendment to Lease, dated April 5, 2021, between GRE Riverworks, LLC and EyePoint Pharmaceuticals, Inc (Filed With SEC on May 5, 2021)
Amendment One to the Commercial Alliance Agreement dated November 12, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Filed With SEC on March 12, 2021)
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors (Filed With SEC on March 12, 2021)
Exclusive License Agreement, dated February 3, 2020, between EyePoint Pharmaceuticals, Inc. and Equinox Science, LLC (Filed With SEC on March 16, 2020)
Amendment No. 3 and Waiver To Term Loan Agreement, dated May 3, 2021, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on May 5, 2021)
Royalty Purchase Agreement, dated December 17, 2020, by and between EyePoint Pharmaceuticals, Inc. and SWK Funding, LLC (Filed With SEC on March 12, 2021)
Description of Securities of EyePoint Pharmaceuticals, Inc (Filed With SEC on March 12, 2021)
First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on February 3, 2021)
Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on February 3, 2021)
Voting and Investor Rights Agreement, dated December 31, 2020, by and among EyePoint Pharmaceuticals, Inc., Ocumension Therapeutics, and EW Healthcare Partners, L.P. and EW... (Filed With SEC on January 4, 2021)
Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on January 4, 2021)
Commercial Alliance Agreement, dated as of August 1, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Filed With SEC on November 6, 2020)
Amendment No. 2 and Waiver To Term Loan Agreement, dated October 8, 2020, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on October 8, 2020)
Controlled Equity OfferingSM Sales Agreement, dated August 5, 2020, by and between EyePoint Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 5, 2020)
Description of Securities of EyePoint Pharmaceuticals, Inc (Filed With SEC on March 16, 2020)
Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 24, 2020)
Waiver To Term Loan Agreement, dated November 19, 2019, among EyePoint Pharmaceuticals, as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as subsidiary... (Filed With SEC on November 22, 2019)
Employment Agreement, dated November 14, 2019, by and between EyePoint Pharmaceuticals, Inc. and George Elston (Filed With SEC on November 19, 2019)
Form of Indemnification Agreement between EyePoint Pharmaceuticals, Inc. and its officers and directors (Filed With SEC on August 7, 2019)
Employment Agreement between EyePoint Pharmaceuticals, Inc. and Scott Jones, dated May 30, 2019 (Filed With SEC on August 7, 2019)
EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 28, 2019)
Amendment No. 1 to EyePoint Pharmaceuticals, Inc. 2016 Long Term Incentive Plan (Filed With SEC on June 28, 2019)
EyePoint Pharmaceuticals, Inc. 2016 Long Term Incentive Plan (Filed With SEC on June 28, 2019)
Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on April 1, 2019)
Fee Letter, dated February 13, 2019, by and between EyePoint Pharmaceuticals, Inc. and CRG Servicing LLC (Filed With SEC on February 19, 2019)
Term Loan Agreement, dated February 13, 2019, among EyePoint Pharmaceuticals, Inc., as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as Subsidiary... (Filed With SEC on February 19, 2019)
At Market Issuance Sales Agreement, dated January 18, 2019, between EyePoint Pharmaceuticals, Inc. and B. Riley FBR, Inc (Filed With SEC on January 18, 2019)